Why is Torrent Pharmaceuticals Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.66% over the last 5 years
2
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 09-Apr-25 and has generated 1.76% returns since then
- The stocks Bollinger Band and KST technical factors are also Bearish
3
With ROCE of 29.6, it has a Very Expensive valuation with a 11.4 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 22.82%, its profits have risen by 30% ; the PEG ratio of the company is 1.9
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -2.94% over the previous quarter and currently hold 68.31% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Torrent Pharma for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Torrent Pharma
22.46%
0.96
23.86%
SENSEX
0.45%
0.03
14.48%
Quality key factors
Factor
Value
Sales Growth (5y)
7.66%
EBIT Growth (5y)
14.43%
EBIT to Interest (avg)
6.97
Debt to EBITDA (avg)
1.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.87
Tax Ratio
29.44%
Dividend Payout Ratio
57.21%
Pledged Shares
0
Institutional Holding
24.52%
ROCE (avg)
21.09%
ROE (avg)
21.25%
Valuation Key Factors 
Factor
Value
P/E Ratio
57
Industry P/E
33
Price to Book Value
14.03
EV to EBIT
37.71
EV to EBITDA
29.45
EV to Capital Employed
11.41
EV to Sales
9.48
PEG Ratio
1.88
Dividend Yield
1.03%
ROCE (Latest)
29.63%
ROE (Latest)
23.19%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
14What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 16.04 times
ROCE(HY)
Highest at 26.24 %
DEBT-EQUITY RATIO(HY)
Lowest at 0.42 times
DEBTORS TURNOVER RATIO(HY)
Highest at 6.19 times
PAT(Q)
Highest at Rs 503.00 cr.
EPS(Q)
Highest at Rs 14.86
-3What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Torrent Pharma
Operating Profit to Interest - Quarterly
Highest at 16.04 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
Highest at Rs 503.00 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 14.86
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 0.42 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Highest at 6.19 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Torrent Pharma
Non Operating Income - Quarterly
Highest at Rs 33.00 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income